FIELD: biotechnology; medicine.
SUBSTANCE: use of Pediococcus inopinatus bacteria, their culture, lysate, pulverized product, or extract as an active component of a food composition, a pharmaceutical composition, or a fodder additive is proposed for improvement of memory, cognitive function, muscular strength, or motor ability. A method for the treatment of a neurodegenerative disease is proposed, including administration of therapeutically effective amount of Pediococcus inopinatus bacteria, their culture, lysate, pulverized product, or extract to a subject who needs it.
EFFECT: inventions provide improvement of ataxia in an animal model of Parkinson disease, and they can be used for prevention, relief of symptoms, and treatment of different neurodegenerative diseases, including Parkinson disease.
12 cl, 5 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LACTOBACILLUS PLANTARUM STRAIN KBL396 AND APPLICATION THEREOF | 2019 |
|
RU2764639C1 |
| COMPOSITION FOR PREVENTING, IMPROVING OR TREATING OBESITY OR FATTY LIVER DISEASE CONTAINING LEUCONOSTOC CITREUM WiKim0104 | 2020 |
|
RU2816754C2 |
| LACTOBACILLUS CRISPATUS KBL693 STRAIN AND ITS APPLICATION | 2019 |
|
RU2791561C2 |
| LACTOBACILLUS PARACASEI STRAIN AND ITS USE | 2019 |
|
RU2790297C2 |
| STRAIN LACTOBACILLUS GASSERI KBL697 AND ITS USE | 2019 |
|
RU2798872C2 |
| LACTOBACILLUS FERMENTUM U-21 STRAIN, WHICH PRODUCES COMPLEX OF BIOLOGICALLY ACTIVE SUBSTANCES WHICH NEUTRALIZE SUPEROXIDE ANION INDUCED BY CHEMICAL AGENTS | 2018 |
|
RU2705250C2 |
| GLUTATHIONE-PRODUCING YEAST STRAIN AND A METHOD OF PRODUCING GLUTATHIONE USING THE SAME | 2020 |
|
RU2800992C1 |
| PROBIOTIC COMPOSITION FOR APPLICATION IN TREATMENT OF INTESTINAL INFLAMMATION | 2011 |
|
RU2563525C2 |
| THERAPEUTIC DRUG FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES AND ITS USE | 2019 |
|
RU2799454C2 |
| NEW LACTIC ACID BACTERIA AND THEIR USE | 2018 |
|
RU2778773C2 |
